Lucid Diagnostics Inc. (LUCD) Return on equity 2021–2025
Lucid Diagnostics Inc. (LUCD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-530.4%FY2025 · since FY2021: -51.3% → -530.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -530.4% | +314.1 pp |
| FY2024 | -844.5% | — |
| FY2022 | -243.7% | -192.4 pp |
| FY2021 | -51.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice